CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway
- 6 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammation
- Vol. 44 (3), 1023-1034
- https://doi.org/10.1007/s10753-020-01398-4
Abstract
Cerebral ischemia-reperfusion (I/R) injury is an inflammation-related disease. CHRFAM7A can regulate inflammatory responses. Therefore, the present study investigated the mechanism of CHRFAM7A in cerebral I/R injury. CHRFAM7A expression and inflammatory cytokine levels in patients with cerebral I/R injury and oxygen-glucose deprivation/reperfusion (OGD/R)-treated microglia were detected. The proliferation, inflammatory cytokine expressions, nod-like receptor protein 3 (NLRP3) level, cell pyroptosis, and viability and lactate dehydrogenase (LDH) activity in OGD/R-treated microglia were detected after CHRFAM7A overexpression. The NLRP3/Caspase-1 pathway was activated to assess the effect of CHRFAM7A on microglia. Expressions of microglial M1 phenotype marker iNOS and M2 marker Arg1 were detected. Downregulated CHRFAM7A and elevated inflammatory cytokine levels were observed in patients with cerebral I/R injury and OGD/R-treated microglia. In OGD/R-treated microglia, CHRFAM7A overexpression promoted cell proliferation and viability, reduced inflammation and LDH activity, and inhibited NLRP3 inflammasome activation and cell pyroptosis. Mechanically, CHRFAM7A inhibited microglia pyroptosis via inhibiting the NLRP3/Caspase-1 pathway and reduced cell inflammatory injury via promoting microglia polarization from M1 to M2. Overall, CHRFAM7A overexpression attenuated cerebral I/R injury by inhibiting microglia pyroptosis in a NLRP3/Caspase-1 pathway-dependent manner and promoting microglia polarization to M2 phenotype.Keywords
This publication has 46 references indexed in Scilit:
- Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouseExperimental Neurology, 2017
- NLRP3 Is Involved in Ischemia/Reperfusion InjuryCNS & Neurological Disorders - Drug Targets, 2016
- Inflammasomes: mechanism of assembly, regulation and signallingNature Reviews Immunology, 2016
- ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion InjuryOxidative Medicine and Cellular Longevity, 2016
- Temporal Changes of CD68 and α7 Nicotinic Acetylcholine Receptor Expression in Microglia in Alzheimer's Disease-Like Mouse ModelsJournal of Alzheimer's Disease, 2015
- Differential Roles of M1 and M2 Microglia in Neurodegenerative DiseasesMolecular Neurobiology, 2015
- CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injuryJournal of Leukocyte Biology, 2014
- Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: Mechanisms and therapeutic implicationsJournal of Molecular and Cellular Cardiology, 2012
- The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR functionBiochemical Pharmacology, 2011
- Function of Partially Duplicated Human α7 Nicotinic Receptor Subunit CHRFAM7A GeneJournal of Biological Chemistry, 2011